Emixustat Macular Edema and Macular Degeneration Market Analysis and Forecast to 2023

Emixustat (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 By RnRMarketResearch

Browse more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Emixustat (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Emixustat hydrochloride (formerly known as ACU-4429) is an orallydosed VCM that is designed to be selective for rod photoreceptors and is being developed for the treatment of GA associated with dAMD. This was the first internally-developed compound by Acucela, a Seattle-based biotechnology company. Acucela has one issued US patent (No. 7,982,071) and seven pending US patents for emixustat, all of which will expire in or around 2029.

Macular Edema is a condition where fluid accumulates on the macula, leading to vision impairment or in severe cases even vision loss. The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO).

Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Emixustat (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Age-related macular degeneration (AMD) is a painless eye condition which leads to gradual, irreversible, loss of central vision, and is one of the leading causes of blindness among people aged 50 and over in the developed world. Currently the ME and AMD markets are dominated by the use of anti-VEGF monotherapy, however, in recent years, corticosteroid implants have been reaching the ME market which could challenge the stronghold these drugs have in this sector.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Complete Report is available at http://www.rnrmarketresearch.com/emixustat-macular-edema-andmacular-degeneration-forecast-and-market-analysis-to-2023-marketreport.html .

Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Emixustat (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Scope: • Overview of Macular Edema and Macular Degeneration, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

• Detailed information on Emixustat including product description, safety and efficacy profiles as well as a SWOT analysis.

• Sales forecast for Emixustat for the top country from 2013 to 2023.

• Sales information covered for the US, France, Germany, Italy, Spain, UK and Japan.

© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Emixustat (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Reasons to Buy:

• Understand and capitalize by identifying products that are most likely to ensure a robust return.

• Stay ahead of the competition by understanding the changing competitive landscape for Macular Edema and Macular Degeneration.

• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.

• Make more informed business decisions from insightful and indepth analysis of Emixustat performance.

© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Emixustat (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Table of Contents: 1.1 List of Tables 8 1.2 List of Figures 9 2 Introduction 10 2.1 Related Reports 11 3 Disease Overview 13 3.1 Macular Degeneration Overview 13 3.1.1 Etiology and Pathophysiology 15 3.1.2 Classification 19 3.1.3 Symptoms and Diagnosis 21 3.2 Macular Edema Overview 24

Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

Emixustat (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441

RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe.

Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441